New Trends in the Utilization of Intravenous Fluids

dc.contributor.authorTinawi, Mohammad
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2022-10-26T14:25:43Z
dc.date.available2022-10-26T14:25:43Z
dc.date.issued2021-04-21
dc.description.abstractIntravenous fluids (IVFs) are the most commonly used drugs in hospitalized patients. Knowledge of the indications and pharmacokinetics of IVFs is critical for all medical disciplines. Isotonic saline (normal saline, 0.9% NS) is the most utilized intravenous solution. Isotonic saline effectively expands the intravascular compartment, as one-quarter of the infusate goes intravascularly, while the remaining three-quarters go into the interstitial space. The proper use of IVFs in different clinical scenarios is paramount. IVFs differ with regard to their half-life, intravascular volume expansion, preparation, and cost. Crystalloids are more commonly utilized due to their relatively low cost and availability. Colloids are very advantageous in cases of shock or hemorrhage, as they remain in the intravascular space, thus facilitating an increase in blood pressure (BP) prior to blood administration. Colloids are also advantageous in cases of burns and severe hypoglobulinemia. Human albumin (5%, 20%, and 25%) is the most used colloid solution. It remains intravascularly provided and there is no capillary leak as in systematic inflammation. The goal in hospitalized patients is timely and adequate intravenous fluid resuscitation. Utilization of a large volume of isotonic saline may lead to hypervolemia, hypernatremia, hyperchloremia, metabolic acidosis, and hypokalemia. The use of balanced intravenous solutions has been advocated to avoid these complications.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationTinawi M. New Trends in the Utilization of Intravenous Fluids. Cureus. 2021;13(4):e14619. Published 2021 Apr 21. doi:10.7759/cureus.14619en_US
dc.identifier.urihttps://hdl.handle.net/1805/30416
dc.language.isoen_USen_US
dc.publisherCureusen_US
dc.relation.isversionof10.7759/cureus.14619en_US
dc.relation.journalCureusen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePMCen_US
dc.subjectIntravenous fluidsen_US
dc.subjectCrystalloid solutionsen_US
dc.subjectColloid solutionsen_US
dc.subjectFluid resuscitationen_US
dc.subjectAlbuminen_US
dc.subjectHydroxyethyl starchen_US
dc.subjectIsotonic salineen_US
dc.subjectLactated ringeren_US
dc.subjectBalanced solutionsen_US
dc.subjectPlasma-lyteen_US
dc.titleNew Trends in the Utilization of Intravenous Fluidsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
cureus-0013-00000014619.pdf
Size:
196.38 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: